Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement
Mark R. Hutchinson(The University of Adelaide), Linda R. Watkins(University of Colorado Boulder), Sondra T. Bland(University of Colorado Denver), Ryan K. Bachtell, Takato Hiranita(The University of Texas at San Antonio Health Science Center), Hang Yin(Cornell University), N. E. Miles, C. Sfregola, Keith A. Strand(Applied DNA Sciences (United States)), Monika Fleshner(University of Colorado Boulder), Lisa C. Loram(Center for Neurosciences), Thomas Maslanik(Center for Neuroscience and Regenerative Medicine), Alexis L. Northcutt, Jonathan L. Katz(University of Southern California), Erika L. Galer(University of Colorado Boulder), Robert R. Rozeske, K. van Steeg(Utrecht University), Susannah S. Lewis, Theresa Kopajtic(National Institutes of Health), Kenner C. Rice(National Institute on Drug Abuse), Tobias R. Chapman(University of Washington), Andrew A. Somogyi(National Council for Palliative Care), Xiaohui Wang(Henan Academy of Sciences), José Amat, Jacob Thomas, Steven F. Maier(University of Colorado Boulder)
Cited by 349
Related Papers
Evidence that opioids may have toll-like receptor 4 and MD-2 effects
|Brain Behavior and Immunity|2009|574
Morphine activates neuroinflammation in a manner parallel to endotoxin
|Proceedings of the National Academy of Sciences|2012|512
Strategies for Targeting Protein–Protein Interactions With Synthetic Agents
|Angewandte Chemie International Edition|2005|449
Magnetic sensitivity of cryptochrome 4 from a migratory songbird
|Nature|2021|444
Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation
|Proceedings of the National Academy of Sciences|2016|378